US 7,425,613 B2
PRO1375 polypeptides
Audrey Goddard, San Francisco, Calif. (US); Paul J. Godowski, Hillsborough, Calif. (US); Austin L. Gurney, Belmont, Calif. (US); Timothy A. Stewart, San Francisco, Calif. (US); and William I. Wood, Hillsborough, Calif. (US)
Assigned to Genentech, Inc., South San Francisco, Calif. (US)
Filed on Apr. 05, 2005, as Appl. No. 11/100,159.
Application 11/100159 is a continuation of application No. 09/997573, filed on Nov. 15, 2001.
Application 09/997573 is a continuation of application No. 09/941992, filed on Aug. 28, 2001.
Application 09/941992 is a continuation of application No. PCT/US00/08439, filed on Mar. 30, 2000.
Application PCT/US00/08439 is a continuation in part of application No. 09/380137, abandoned, previously published as PCT/US99/12252, filed on Jun. 02, 1999.
Claims priority of provisional application 60/144758, filed on Jul. 20, 1999.
Claims priority of provisional application 60/096894, filed on Aug. 17, 1998.
Prior Publication US 2005/0196840 A1, Sep. 08, 2005
Int. Cl. C07K 14/435 (2006.01); C12N 15/24 (2006.01); C12N 15/64 (2006.01); C12P 21/02 (2006.01)
U.S. Cl. 530—350  [424/85.2; 435/320.1; 435/471; 435/69.5; 536/23.5] 6 Claims
 
1. An isolated polypeptide having at least 95% amino acid sequence identity to:
(a) the amino acid sequence of the polypeptide of SEQ ID NO: 2; or
(b) the amino acid sequence of the polypeptide encoded by the full-length coding sequence of the cDNA deposited under ATCC® accession number 203115,
wherein said polypeptide enhances the uptake of glucose or FFA (free fatty acid) by adipocyte cells.